H. Lundbeck A/S (CPH:HLUN.B)
Denmark
· Delayed Price · Currency is DKK 38.10
+0.32 (0.85%)
At close: Mar 9, 2026
H. Lundbeck Revenue
In the year 2025, H. Lundbeck had annual revenue of 24.63B DKK with 11.93% growth. H. Lundbeck had revenue of 6.09B in the quarter ending December 31, 2025, with 9.96% growth.
Revenue
24.63B
Revenue Growth
+11.93%
P/S Ratio
1.49
Revenue / Employee
4.89M
Employees
5,039
Market Cap
36.71B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 24.63B | 2.63B | 11.93% |
| Dec 31, 2024 | 22.00B | 2.09B | 10.51% |
| Dec 31, 2023 | 19.91B | 1.67B | 9.13% |
| Dec 31, 2022 | 18.25B | 1.95B | 11.95% |
| Dec 31, 2021 | 16.30B | -1.37B | -7.77% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Novo Nordisk | 309.06B |
| Genmab | 23.66B |
| Coloplast | 27.89B |
| ALK-Abelló | 6.31B |
| Demant | 22.97B |
| Ambu A/S | 6.09B |
| Zealand Pharma | 9.21B |
| Bavarian Nordic | 6.89B |